Abstract:Metabolomic is generally characterized as a comprehensive and the most copious analytical technique for the identification of targeted and untargeted metabolite diversity in a biological system. Recently, it has exponentially been used for phytochemical analysis and variability among plant metabolites, followed by chemometric analysis. Network pharmacology analysis is a computational technique used for the determination of multi-mechanistic and therapeutic evaluation of chemicals via interaction with the genomes involved in targeted or untargeted diseases. In considering the facts, the present review aims to explore the role of metabolomics and network pharmacology in the scientific validation of therapeutic claims as well as to evaluate the multi-targeted therapeutic approach of traditional Indian medicinal plants. The data was collected from different electronic scientific databases such as Google Scholar, Science Direct, ACS publication, PubMed, Springer, etc., using different keywords such as metabolomics, techniques used in metabolomics, chemometric analysis, a bioinformatic tool for drug discovery and development, network pharmacology, methodology and its role in biological evaluation of chemicals, etc. The screened articles were gathered and evaluated by different experts for their exclusion and inclusion in the final draft of the manuscript. The review findings suggest that metabolomics is one of the recent most precious and effective techniques for metabolite identification in the plant matrix. Various chemometric techniques are copiously used for metabolites discrimination analysis hence validating the unique characteristic of herbal medicines and their derived products concerning their authenticity. Network pharmacology remains the only option for the unique and effective analysis of hundreds of chemicals or metabolites via genomic interaction and thus validating the multi-mechanistic and therapeutic approach to explore the pharmacological aspects of herbal medicines for the management of the disease.

Metabolomics‐driven Approaches for Identifying Therapeutic Targets in Drug Discovery

Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification

Metabolomics: Bridging Chemistry and Biology in Drug Discovery and Development

Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics

Metabolomics in Drug Target Discovery

Advances in Integrated Multi-omics Analysis for Drug-Target Identification

Target identification of natural and traditional medicines with quantitative chemical proteomics approaches.

Protein target discovery of drug and its reactive intermediate metabolite by using proteomic strategy

Recent advances and method development for drug target identification

Pharmacometabolomics in Drug Disposition, Toxicity and Precision Medicine

Metabolomics in Drug Research and Development: the Recent Advances in Technologies and Applications

Chemical Proteomics: Terra Incognita for Novel Drug Target Profiling

Small molecule metabolites: discovery of biomarkers and therapeutic targets

Metabolomics and Network Pharmacology in the Exploration of the Multi-Targeted Therapeutic Approach of Traditional Medicinal Plants

Functional metabolomics innovates therapeutic discovery of traditional Chinese medicine derived functional compounds

[Multi-Target Therapeutics and New Drug Discovery].

Trends in the Exploration of Therapeutic Targets for the Treatment of Endocrine, Metabolic and Immune Disorders

[Chemical Proteomics and Discovery of Drug Targets].

Metabolomics as a Truly Translational Tool for Precision Medicine

Application of omics- and multi-omics-based techniques for natural product target discovery

Chemoproteomics: Towards Global Drug Target Profiling